RNA interference (RNAi) is a conserved eukaryotic mechanism by which double-stranded RNA (dsRNA) triggers the sequence-specific degradation of homologous mRNAs. Recent concerns have arisen in mammalian systems about off-target effects of RNAi, as well as an interferon response. Most mammalian cells respond to long dsRNAs by inducing an antiviral response mediated by interferon that leads to general inhibition of protein synthesis and nonspecific degradation of mRNAs. Moreover, recent reports demonstrate that under certain conditions, short interfering RNAs (siRNAs, 21 -25 bp) may activate the interferon system. Mouse oocytes and preimplantation embryos apparently lack this response, as potent and specific inhibition of gene expression triggered by long dsRNA is observed in these cells. In the present study, we analyzed the global pattern of gene expression by microarray analysis in transgenic mouse oocytes expressing long dsRNA and find no evidence of off-targeting. We also report that genes involved in the interferon response pathway are not expressed in mouse oocytes, even after exposure for an extended period of time to long dsRNA. D
Introduction
RNA interference (RNAi) is a conserved post-transcriptional gene silencing mechanism present in most eukaryotes wherein double-stranded RNA (dsRNA) triggers the sequence-specific degradation of cognate mRNAs (Denli and Hannon, 2003) . We have developed a transgenic RNAi approach to study gene function during oocyte development. The approach is based on using the oocyte-specific Zp3 promoter to drive expression of a long hairpin dsRNA that contains sequence complementary to the gene under investigation. The transgene is carried in the male, who is mated to a wild-type female, and transgenic female F1 offspring are used as the source of oocytes; non-transgenic female littermates serve as controls (Stein et al., 2003) .
We validated this transgenic RNAi approach by targeting Mos. RNAi transgenic oocytes recapitulate the Mos null phenotype, i.e., failure to activate MAP kinase and arrest at metaphase II, and a high frequency of spontaneous parthenogenetic activation (Stein et al., 2003) . This transgenic RNAi approach has been extended to study the function of three other genes (Ctcf, Msy2, basonuclin) in oocytes and early embryos (Fedoriw et al., 2004; Yu et al., 2004; Ma et al., unpublished results) . For each gene studied, a specific phenotype consistent with the target gene's known or proposed function is observed.
An advantage of the transgenic RNAi approach when compared to a conventional knockout approach, besides being technically simpler, is that it usually generates a range of expression. This epiallelic series, analogous to a hypomorphic series of mutants, typically yields a range of informative phenotypes that provide critical insights into gene function. For example, the epiallelic series of transgenic Mos RNAi oocytes reveals that only 10 -15% of the maximal amount of MAP kinase activity is required to maintain metaphase II arrest (Stein et al., 2003) .
Although RNAi is observed from yeast to humans, mammalian cells possess another pathway that responds to long dsRNA by inducing interferon (IFN) a and h expression and activating two dsRNA-dependent enzymes, namely, dsRNA-dependent protein kinase (PKR) and 2V, 5V oligoade-nylate synthetase (OAS) (Samuel, 2001) . PKR autophosphorylates in response to dsRNA and subsequently phosphorylates its substrates, one of which is the a subunit of the eukaryotic translation initiation factor 2 (eIF2a); this post-translational modification leads to a general inhibition of protein synthesis. OAS, on the other hand, undergoes a conformational change upon binding dsRNA and becomes activated to convert ATP to 2V5V-linked oligoadenylates of different lengths (2 -5A). These 2 -5A bind and activate a latent ribonuclease, RNase L, that catalyses the nonspecific degradation of cellular or viral RNAs (Samuel, 2001 ). In addition, activation of PKR and RNase L is linked to apoptosis (Tan and Katze, 1999; Zhou et al., 1997) . This antiviral pathway is known as the interferon response.
The mechanism of action of type I IFNs (a/h) involves binding to cell surface specific receptors and activating the JAK -STAT pathway (Samuel, 2001 ). This signaling cascade leads to the activation of transcription of hundreds of genes, named IFN-stimulated genes or ISG (Sarkar and Sen, 2004) . PKR, the OAS family, and RNase L are within these ISG and both PKR and OAS are dually regulated, transcriptionally by IFN a and h and post-translationally by binding to dsRNA (Jacobs and Langland, 1996) .
dsRNA by itself, even in the absence of IFN, can transcriptionally activate several hundred of genes, collectively named DSG (dsRNA-stimulated genes). Some of these DSGs are also activated by IFN. Yet expression of other genes is repressed by dsRNA. Thus, dsRNA is a potent and global modulator of gene expression in mammalian cells (Sarkar and Sen, 2004) .
Unlike PKR and Rnase L that are encoded by single genes, mouse OAS is a family of proteins encoded by 12 different genes (Oas1a to 1h, Oas2, Oas3, and Oasl1 and l2) located in a cluster on chromosome 5 (Eskildsen et al., 2002) . While all mouse OAS proteins bind dsRNA, only a few of them have catalytic activity (OAS1A, OAS1G, OAS2, OAS3, and OASL2) (Kakuta et al., 2002) . The different isoforms have different tissue distribution, with OAS1A, 1G, 2, L1, and L2 highly expressed in digestive and lymphoid organs and OAS1C, D, E, and H highly expressed in the ovary (Kakuta et al., 2002) .
The antiviral response is likely missing in some mammalian cell types because long dsRNA triggers sequence-specific mRNA degradation in mouse oocytes and early embryos, undifferentiated mouse embryonic stem cells, undifferentiated mouse embryonal carcinoma cells, differentiated mouse neuroblastoma cells, human peripheral blood mononuclear cells, rat hypothalamus, and muscle cells (Svoboda et al., 2000; Wianny and Zernicka-Goetz, 2000; Yang et al., 2001; Billy et al., 2001; Gan et al., 2002; Park et al., 2002; Bhargava et al., 2004; Yi et al., 2003; Kong et al., 2004) . The reason for the absence of a nonspecific response in these cell types is unknown.
The nonspecific effects caused by activating the IFN pathway initially severely hampered applying RNAi in many mammalian cell types. This problem was apparently circumvented by finding that short interfering RNAs (siRNAs), rather than long dsRNA, effectively knock-down the amount of transcript of a given gene without activating the IFN system (Harborth et al., 2001; Yu et al., 2002) . Recent reports, however, suggest that siRNAs may also activate components of the interferon system, thus potentially affecting gene expression more broadly (Kim et al., 2004; Sledz et al., 2003; Bridge et al., 2003) . In addition, other recent studies have drawn attention to the existence of off-target effects of RNAi, i.e., silencing of non-targeted genes containing partial sequence identity to the siRNA (Jackson et al., 2003; Persengiev et al., 2004) . Because these studies were performed using siRNAs to trigger RNAi, it is not known whether similar nonspecific effects are generated by long dsRNA. Furthermore, it is not known if expressing dsRNA constitutively from a transgene, rather than by transfection or viral infection, avoids the nonspecific response.
Although we never observed any evidence of nonspecific effects in transgenic oocytes for the genes studied to date, it is possible that such effects were not detected by the methods used. In the present study, we used microarray analysis to compare the global pattern of gene expression in wild-type oocytes and oocytes exposed for an extended period of time to long dsRNA. Our results show that RNAi is extremely specific in that no interferon response and no off-target effects are detected. The likely basis for the lack of an interferon-like response is that oocytes do not express genes essential for this pathway, but do express inhibitory forms of OAS.
Materials and methods

Animals
The female mice used in this study were the second and third generation (F2, F3) from Mos RNAi transgenic founder male #H13 (B6SJLF1/J background) obtained by mating to wild-type CF1 females (Stein et al., 2003) . Oocyte collection was performed as previously described (Schultz et al., 1983) . All animal experiments were approved by the Institutional Animal Use and Care Committee and were consistent with National Institutes of Health guidelines.
RNA isolation, Affymetrix oligonucleotide array hybridization, and data analysis
Total RNA isolation, double amplification, and array hybridization were performed as previously described (Zeng et al., 2004) . Briefly, RNA was prepared from 30 fully-grown oocytes isolated from individual mice by using PicoPure RNA isolation kit (Arcturus, Mountain View, CA) according to the manufacturer's instructions. Four transgenic and four wild-type animals were used to have 4 replicates per group for the microarray analysis. Probes for microarray analysis were hybridized to the MOE430A mouse GeneChip (Affymetrix, Santa Clara, CA). The hybridized arrays were scanned and raw data extracted by using Microarray Analysis Suite 5.0 software (Affymetrix). GeneSpring 6.2 software (Silicon Genetics, Redwood City, CA) was used to analyze differential expression.
Quantitative real-time PCR
Total RNA was extracted from fully-grown oocytes from wild-type and transgenic animals by using Absolutely RNA\ Microprep Kit (Stratagene, La Jolla, CA) according to the manufacturer's instructions. cDNA was prepared by reverse transcription of total RNA with Superscript II enzyme and random hexamer primers. One to two oocyte equivalents of the resulting cDNA were amplified using TaqMan probes and the ABI Prism Sequence Detection System 7000 (Applied Biosystems, Foster City, CA) according to the manufacturer's protocols. Three replicates were used for each real-time PCR reaction; a minus RT and a minus template served as controls. Quantification was normalized to the endogenous histone H2a or upstream binding factor (Ubf) within the loglinear phase of the amplification curve obtained for each probe/primer using the comparative C T method (ABI PRISM 7700 Sequence Detection System, User Bulletin #2, Applied Biosystems, 1997). The TaqMan gene expression assays used were:
For Mos, the custom TaqMan Gene Expression Assay used had the following primers and probes: forward primer 5VGGGAACAGGTATGTCTGATGCA3V, reverse primer 5VCACCGTGGTAAGTGGCTTTATACA3V, probe 5VFAM CCGAGCCAAACCCTC3V.
Immunoblotting
Equal numbers of oocytes from transgenic and wild-type mice were transferred to 0.5-ml microcentrifuge tubes containing 10 Al of doubleconcentrated Laemmli sample buffer. The oocyte extracts were electrophoresed in a 10% polyacrylamide-sodium dodecyl sulfate (SDS) gel and transferred to a PVDF membrane using semi-dry transfer. The membrane was blocked overnight at 4-C with ECLi Advance Blocking Agent (2% w/v) dissolved in Tris-buffered saline (TBS) containing 0.1% Tween 20 (TTBS). The membrane was then probed with mouse monoclonal antibody B-10 against PKR (Santa Cruz Biotechnology Inc., Santa Cruz, CA) at a 1:100 dilution, followed by horseradish peroxidase-conjugated secondary antibody (donkey anti-mouse IgG; Jackson ImmunoResearch, West Grove, The graph depicts quantification of results of three independent experiments, normalized using either histone H2a or upstream binding factor (Ubf) as internal control; similar results were obtained using either standard. The fold change was calculated using the comparative C T method. The data are expressed as the mean T SEM. *, the difference compared to a ratio of 1.0 (WT = KD) is significant; P < 0.05, one-way ANOVA. PA) at a 1:200,000 dilution. Both primary and secondary antibodies were diluted in blocking solution and incubated for 1 h at room temperature; the membrane was washed four times in TTBS after each incubation. The signal was developed using ECLi Advance Western Blotting System (Amersham Biosciences, Piscataway, NY). NIH/3T3 whole cell lysates (Santa Cruz Biotechnology Inc.) were used as positive control for the presence of PKR.
Results and discussion
To assess if any off-target effects or an interferon response is present in mouse oocytes as a result of RNAi, we analyzed the transcriptome in oocytes exposed to long dsRNA. We chose the Mos RNAi transgenic mouse oocyte as a model system. Mos is a dormant maternal message -Mos mRNA accumulates but is not translated during oocyte growth; translation starts following resumption of meiosis (Gebauer and Richter, 1997 ) -and hence targeting Mos mRNA should not affect the relative abundance of any other transcript in the oocyte. Therefore, any differences in transcript abundance between wild-type and Mos RNAi transgenic oocytes must be due exclusively to the effects of dsRNA.
We have generated two lines of transgenic Mos RNAi mice that display different degrees of targeting endogenous Mos mRNA (Stein et al., 2003) . We chose to conduct the expression profiling experiments with the line that displays the greatest reduction in endogenous Mos mRNA because these oocytes would presumably have the highest likelihood of exhibiting non-specific effects, i.e., this line would have the highest degree of expression of dsRNA and highest level of siRNAs derived from the long hairpin Mos dsRNA.
Expression profiling of fully-grown, germinal vesicle (GV)-intact oocytes from Mos RNAi transgenic female mice (Mos knockdown; KD (Stein et al., 2003) ) and from wild-type littermates (WT) was performed using Affymetrix oligonucleotide GeneChips; 10,118 genes on the MOE430A chip (44.6%) were detected, which is within the normal range for the ''A'' chip. Consistent with no widespread nonspecific targeting effects, hierarchical clustering using all the genes detected showed that all samples (WT and KD) cluster together (data not shown). Furthermore, when one-way ANOVA analysis for microarrays (http://lgsun.grc.nia.nih.gov/ANOVA/index.html, default parameters) was performed to identify differentially expressed genes, only eight genes were found to be significantly different in KD oocytes vs. WT oocytes; four of them are increased in KD compared to WT and four are decreased (Fig. 1A and Table 1 ). As anticipated, Mos is among the four under-expressed genes and has the highest signal intensity of all eight genes. Note that except for Mos, the other seven genes in the list exhibit low levels of expression. The other three genes that are under-expressed in transgenic oocytes do not share any sequence similarity with Mos or among themselves nor do they belong to a common pathway. The same is true for the four up-regulated genes.
We next performed quantitative real-time RT-PCR analysis to validate the expression patterns of the differentially expressed genes. We elected to test only those genes with at least one present call in one of the eight samples (flag filter, Microarray Analysis Suite 5.0, Affymetrix). Fig. 1B shows that Mos was indeed the only differentially expressed transcript in transgenic oocytes (10.2% of WT levels).
To assess if an interferon response was present in KD oocytes, we searched for interferon-stimulated genes (ISG) in our gene list, in particular within the up-regulated genes. None of the eight genes that showed differential expression between KD and WT oocytes are known ISGs. Similarly, none of the genes that have been described as dsRNA-regulated in somatic cells (DSG) showed differential expression between KD and WT samples. In fact, when we searched for interferons and their receptors in our data set, we found very low levels of expression of all of them and no difference whatsoever between WT and KD oocytes (data not shown). Riego et al. (1995) reported the presence of IFN-alpha mRNA in mouse eggs and early embryos and Truchet et al. (2004) suggested that signaling by type I IFNs is functional in mouse oocytes. Conversely, Zusman et al. (1984) concluded that preimplantation mouse embryos appear to be resistant for both the antiviral and antiproliferative activities of IFN. Our results show that long dsRNA does not induce IFN production in mouse oocytes.
In light of the aforementioned results, we analyzed the expression profiles of the genes involved in the interferon response, namely Pkr, Oas, and Rnasel (Table 2) . Interestingly, the OAS/RNase L arm of the pathway appears to be missing in mouse oocytes. Both OAS isoforms that have catalytic activity (Oas1g, Oas2, Oas3, and Oasl2) and Rnasel are absent according to the microarray results. On the other hand, some of the inactive isoforms (Oas1c, 1d, and 1e), which are believed to act as dominant negatives (Yan et al., 2005) , are expressed at very high levels. Note that Oas1a and 1f are not represented on the MOE430A chip. As for Pkr, the levels of expression are very low as well, with one of the probe sets having an absent call, while the second one has some marginal and present calls. For all 12 genes analyzed, there was no statistical difference in expression between WT and KD oocytes.
We validated the results of the microarray analysis by quantitative real-time RT-PCR. We measured the levels of representative transcripts, including Pkr, Rnasel, and in particular Oas1a, which is an active OAS that is not represented on the A chip. Fig. 2 shows the graphs from a representative experiment for 8 different genes involved in the interferon response; Mos levels were also measured as a control. Oas1a, Oas1g, Oas2, Pkr, and Rnasel are absent or present at extremely low levels, while Oas1c, 1d, and 1e are abundantly expressed. Using the combined data from three experiments and the DDC T method, we determined that there was no significant difference in transcript levels between WT and KD oocytes for any of the 8 genes tested. Therefore, realtime RT-PCR experiments confirm the results obtained using microarrays.
Of note, Yan et al. (2005) reported the presence of OAS1A in mouse oocytes and showed that OAS1D directly interacts with OAS1A and inhibits its activity. The authors generated mice deficient in OAS1D and found that, although null females display reduced fertility, their oocytes do not mount an interferon response to dsRNA injection. This result indicates that the high levels of OAS1C and OAS1E in oocytes are still sufficient to prevent the action of OAS1A. Another possibility is that because RNase L is absent or present at very low levels, the OAS/RNase L arm of the pathway does not operate, even in the absence of OAS1D.
Because mRNA levels do not always correlate with protein levels, we proceeded to measure PKR protein levels by immunoblotting (Fig. 3) . Using NIH/3T3 whole cell lysates as positive control, we demonstrated that mouse oocytes have undetectable levels of PKR and that extended exposure to long dsRNA does not increase them. We were unable to measure RNase L protein levels, due to the lack of suitable antibodies. That we did not observe any difference in abundance of cellular mRNAs between WT and KD oocytes in the microarray data set indicates the absence of an active RNase L enzyme. Taken together, the results presented here indicate that the expression of long dsRNA does not trigger an interferon response in mouse oocytes.
We do not know when this antiviral response develops in the embryo but based on expression profiling data (Zeng , 2004) , it is unlikely that a robust response initiates prior to the blastocyst stage because the levels of expression of the genes involved in the interferon response pathway do not increase from the oocyte to the blastocyst stage (Table  3) . Although PKR can be detected by Western blot in blastocysts, albeit at very low levels (data not shown), RNAi triggered by long dsRNA works efficiently in the early embryo until the blastocyst stage Wianny and Zernicka-Goetz, 2000) . RNAi also works efficiently in ES cells, which are derived from the inner cell mass of blastocysts (Yang et al., 2001) . These data indicate that the interferon response most likely becomes active post-implantation.
There are a variety of factors that determine how a specific cell type responds to dsRNA. These include the concentration of dsRNA, the cellular repertoire of proteins involved in RNAi and the IFN response, and the form of administering dsRNA. Both off-target effects and induction of an interferon response by siRNAs are concentration dependent (Kim et al., 2004; Sledz et al., 2003; Jackson et al., 2003) . We do not know what the levels of dsRNA, and hence of siRNAs, are in these transgenic oocytes. Nevertheless, when oocytes from another RNAi transgenic mouse (Ctcf knockdown animals (Fedoriw et al., 2004) ) were subject to a similar approach using Affymetrix oligonucleotide arrays the same result was obtained, namely, the absence of the proteins involved in the interferon response pathway (Wan and Bartolomei, personal communication). Because Ctcf is not a dormant message, we could not look for off-target effects in these oocytes. It is also not known whether dsRNA expressed in the nucleus has the same likelihood of producing off-target effects as dsRNA administered in the cytoplasm, either by microinjection, transfection, or viral infection. For example, liposomal transfection reagents induce IFN synthesis and activate ISGs (Li et al., 1998) . Noteworthy, in numerous experiments where dsRNA was microinjected into the cytoplasm of mouse oocytes or 1-cell embryos we never observed any evidence of apoptosis, even after culturing the embryos to the blastocyst stage (data not shown).
Micro RNAs (miRNAs), single-stranded RNA molecules of 21 -22 nt (Bartel, 2004) , are produced from a hairpin precursor by Dicer, which also initiates the RNAi pathway by cleaving long dsRNA molecules to produce siRNAs. Although initial studies characterized miRNAs as repressors of translation by binding to the 3VUTR of protein-coding mRNAs, it is now clear that both siRNAs and miRNAs can either repress translation when they are mismatched to the target mRNA or lead to mRNA cleavage, when perfectly matched (Bartel, 2004; Doench et al., 2003; Zeng et al., 2003) . In the present study, we assessed the global pattern of gene expression at the transcript level, and therefore cannot exclude the possibility that some off-target effects due to translation blockade by siRNAs or miRNAs exist at the protein level. In fact, nonspecific effects of siRNAs at the protein level have been reported (Scacheri et al., 2004) and although protein and mRNA levels generally correlated, the magnitude of the changes was not always equal.
Despite the fact that the search for off-targeting was performed in only one RNAi transgenic mouse model (Mos KD) and that we cannot rule out the possibility of nonspecific effects at the protein level, we believe that it is unlikely that these off-target effects exist in this transgenic RNAi approach. First, oocytes expressing dsRNA to different genes have phenotypes consistent with the proposed role of the targeted gene. Second, H1foo knockdown mice exhibit no discernable phenotype whatsoever, despite the absence of detectable H1F00 protein (E. Adashi, personal communication). Last, because we only used the Affymetrix A chip it is possible that genes present on the B chip may be mis-regulated in response to long dsRNA.
The results reported here provide further support that transgenic RNAi is highly specific in mouse oocytes and therefore is a robust and simple method to study gene function during oocyte development.
